Kazakhstan’s Ministry of Science continues to test a new domestically produced cancer treatment drug, DVC. The medication is currently being administered to eight patients as part of the second phase of development to establish the maximum dosage patients can safely tolerate, the ministry reported in response to a request from the Informburo media portal.
Researchers from the National Laboratory Astana and the Kazakh Institute of Oncology and Radiology in Almaty are jointly working to determine the maximum tolerated dose of DVC. In this phase, cancer patients who meet specific criteria are receiving up to 36 injections of the drug in...